Literature DB >> 26891749

Fibulin-5 downregulates Ki-67 and inhibits proliferation and invasion of breast cancer cells.

Yamina Mohamedi1, Tania Fontanil1, Laura Solares1, Olivia Garcia-Suárez2, Jorge García-Piqueras2, Jose A Vega2, Santiago Cal1, Alvaro J Obaya3.   

Abstract

Fibulins not only function as molecular bridges within the cellular microenvironment but also influence cell behavior. Thus, fibulins may contribute to create a permissive microenvironment for tumor growth but can also stimulate different mechanisms that may impede tumor progression. This is the case with Fibulin-5, which has been shown to display both tumor-promoting and tumor-protective functions by mechanisms that are not totally defined. We show new evidence on the tumor-protective functions displayed by Fibulin-5 in MCF-7, T47D and MDA-MB-231 breast cancer cells including the inhibition of invasion and proliferation capacity and hampering the ability to form mammospheres. Reduction in the level of phosphorylation of Ser residues involved in the nuclear translocation of β-catenin may underlie these antitumor effects. We also found that Fibulin-5 reduces the level of expression of Ki-67, a nuclear protein associated with cell proliferation. Moreover, reduction in Fibulin-5 expression corresponds to an increase of Ki-67 detection in breast tissue samples. Overall, our data provide new insights into the influence of Fibulin-5 to modify breast cancer cell behavior and contribute to better understand the connections between fibulins and cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26891749     DOI: 10.3892/ijo.2016.3394

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Identification of the matricellular protein Fibulin-5 as a target molecule of glucokinase-mediated calcineurin/NFAT signaling in pancreatic islets.

Authors:  Tomoko Okuyama; Jun Shirakawa; Hiromi Yanagisawa; Mayu Kyohara; Shunsuke Yamazaki; Kazuki Tajima; Yu Togashi; Yasuo Terauchi
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

2.  Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.

Authors:  Tiantian Wang; Mei Wang; Shuang Fang; Qiang Wang; Rui Fang; Jie Chen
Journal:  Oncotarget       Date:  2017-03-21

3.  FBLN5 is targeted by microRNA‑27a‑3p and suppresses tumorigenesis and progression in high‑grade serous ovarian carcinoma.

Authors:  Rongrong Li; Huan Wu; Huiyang Jiang; Qiuman Wang; Zhiyuan Dou; Hanlin Ma; Shi Yan; Cunzhong Yuan; Ning Yang; Beihua Kong
Journal:  Oncol Rep       Date:  2020-09-03       Impact factor: 3.906

4.  Apatinib inhibits the growth of small cell lung cancer via a mechanism mediated by VEGF, PI3K/Akt and Ki-67/CD31.

Authors:  Ning Zhong; Wei Zhuang; Qian Huang; Qiang Wang; Wenjian Jin
Journal:  J Cell Mol Med       Date:  2021-09-30       Impact factor: 5.310

5.  Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).

Authors:  Yi Li; Xiaojuan Yang; Dan Lu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

6.  Identification of specific biomarkers for gastric adenocarcinoma by ITRAQ proteomic approach.

Authors:  Xiaoxiao Wang; Qiaoming Zhi; Songbai Liu; Sheng-Li Xue; Congcong Shen; Yangxin Li; Chaofan Wu; Zaixiang Tang; Weichang Chen; Jenny Lee Song; Meiyu Bao; Yao-Hua Song; Jin Zhou
Journal:  Sci Rep       Date:  2016-12-12       Impact factor: 4.379

7.  Tropomyosin isoforms have specific effects on the transcriptome of undifferentiated and differentiated B35 neuroblastoma cells.

Authors:  Holly Stefen; Alexandra Kalyna Suchowerska; Bei Jun Chen; Merryn Brettle; Jennifer Kuschelewski; Peter William Gunning; Michael Janitz; Thomas Fath
Journal:  FEBS Open Bio       Date:  2018-02-19       Impact factor: 2.693

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.